FDA to ‘rapidly work’ towards emergency use authorization for Pfizer-BioNTech vaccine

The Foodstuff and Drug Administration explained these days that adhering to yesterday’s optimistic advisory committee meeting final result regarding the Pfizer-BioNTech COVID-19 vaccine, it would fast get the job done towards finalization and issuance of an emergency use authorization for the COVID-19 vaccine. 

The Fda gave no particular timeline.

The agency has also notified the U.S. Centers for Ailment Management and Avoidance and Procedure Warp Speed, so they can execute their designs for well timed vaccine distribution.

Acceptance signifies vaccine distribution would be on Procedure Warp Speed’s timetable for distribution to front-line health care employees and vulnerable populations in extensive-phrase treatment services by mid-thirty day period.

The Fda advisory committee has scheduled one more meeting to evaluate the Moderna vaccine on Thursday, December seventeen.

See our continuing vaccine protection in this article:

Pfizer-BioNTech vaccine gets Fda advisory committee approval

CMS provides guidance in billing Medicare for COVID-19 antibody treatment

Countless numbers in the United Kingdom are the 1st to acquire Pfizer COVID-19 vaccine

Eli Lilly and UnitedHealth Team lover on COVID-19 antibody treatment for significant-threat people today

Procedure Warp Speed is wanting to begin distributing COVID-19 vaccine by mid-thirty day period

Moderna seeks regulatory authorization for its COVID-19 vaccine

HHS will start allocating Regeneron’s COVID-19 therapeutic this 7 days

HHS companions with chain and impartial pharmacies to increase accessibility to future COVID-19 vaccines

COVID-19 vaccine distribution will start inside 24 several hours of an emergency use authorization

Moderna vaccine prospect reveals 94.5% efficacy against COVID-19

Pfizer touts new COVID-19 vaccine, calling it ‘90% effective’

Medicare beneficiaries can get monoclonal antibody COVID-19 solutions at no value

Fda grants emergency use authorization for Eli Lilly antibody treatment for COVID-19

Twitter: @SusanJMorse
Email the author: [email protected]